Trial intelligence / Profile preview

Phase Ia/IIa Trial of IMBCAMS Inactivated SARS-CoV-2 Vaccine (Covidful) in Healthy Adults

NCT04412538Phase 2Completed

Sponsor
Institute of Medical Biology
Start
May 2020
Primary completion
Aug 2020
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of Covidful in coronavirus disease 2019 (COVID-19), sponsored by Institute of Medical Biology. Started May 2020; status: completed.

02

Drugs

Covidful
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04412538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04412538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call